Drug profile · INN
testolactone
TESLAC
testolactone (TESLAC) is a cytochrome p450 19a1 inhibitor. Route of administration: injection. Current US regulatory status: approved.
Drug details — testolactone
- US status
- approved
- Class
- —
- Route
- INJECTION
- Patents
- 0
- Programs
- 0
- Data quality
- 0.84
Quick answer
testolactone (TESLAC) is a cytochrome p450 19a1 inhibitor. Route of administration: injection. Current US regulatory status: approved.
Reviewed by James Park Regulatory Affairs Editor Last reviewed Jun 8, 2026
Key facts
Mechanism of action
Cytochrome P450 19A1 inhibitor
Primary target: Aromatase
Approval history
Regional status spokes: FDA status
| Authority | Status | Date |
|---|---|---|
| FDA | approved | — |
Related & competitor drugs
Frequently asked questions
What is testolactone?
testolactone (TESLAC) is a cytochrome p450 19a1 inhibitor. Route of administration: injection. Current US regulatory status: approved.
What is the brand name for testolactone?
TESLAC is a marketed brand name for testolactone. Check FDA Drugs@FDA for the current US label holder and prescribing information.
What is the US approval status of testolactone?
testolactone has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.